drugset / Trial / NCT01476683

Study to Compare the Pharmacokinetics Profiles of Four Racecadotril Products

NCT01476683 ↗

Phase 1 Completed 24 enrolled McNeil AB
RandomizedCrossoverSingle-blindBasic science

Summary

This study is designed to compare the pharmacokinetics of four products used for treatment of acute diarrhea.

Timeline

Start
2011-12
Primary completion
2011-12
Completion
2011-12

Drugs

EvaluationDrugModalityDoseRoute
Comparator Racecadotril Small molecule 175 mg Oral
Comparator Racecadotril Small molecule 200 mg Oral

Indications